A long history of innovation and impact

We bring together a unique blend of world-leading doctors and scientists, seasoned entrepreneurs, and experienced investors with decades of expertise at the forefront of Medicine, Technology, and Investment.

Our scientific advisors are internationally recognized experts in Neuroscience and Surgery, Biomedical Engineering, Healthcare Technologies, Clinical Trial Optimization, AI, and Data Science. This diverse expertise empowers us to drive innovation and deliver meaningful impact.

Dr Elad I. Ely MD MBA FACS FAHA

ChAIR of the Scientific Adcisory board

Dr Aimee DeGaetano PhD, MPH, RD

HEAD OF EMERGING RESEARCH & TECHNOLOGIES

Dr Vadim Pinskiy

CHIEF TECHNOLOGY OFFICER, DATA & AI

Aris Kekedjan

Managing partner, Alts VenturES

Julien Nicod

Managing partner, Alts Ventures

Former CIO (Chief Investment Officer) at General Electric (NYSE: GE) and CEO at Trinity Life Sciences, and previously CEO at Carl Icahn Holdings

Founder of Alts Ecosystem, an innovative investment firm. Seasoned Entrepreneur and Investor across a range of asset classes and institutions.

Former Portfolio Manager with experience across a range of asset classes and situations in top-tier investment management firms

Elad I. Levy is Professor of Neurosurgery and Radiology and Chair of Neurological Surgery at the Jacobs School of Medicine, SUNY Buffalo. He has co-authored over 500 peer-reviewed publications, served on the CNS Executive Committee since 2007, and is a past president of the CNS Foundation, where he helped launch global philanthropic initiatives. He currently serves as Vice Chair of the American Board of Neurological Surgery and Endovascular Section Editor for Neurosurgery. Dr. Levy is internationally recognized for his leadership in advancing neurovascular care, education, and innovation.

Aimee de Gaetano is a leading expert in neurological innovation, clinical strategy, and global medical affairs, with a background spanning clinical research, digital health, and technology development. She has authored over 500 abstracts and clinical manuscripts and has led multi-institutional initiatives focused on patient-centered care and translational research. Aimee has also served in advisory roles across academia, industry, and nonprofit sectors, shaping global strategies in neurology and neurotechnology.

Dr. Vadim Pinskiy is a neuroscientist and technology leader with deep expertise in biomedical engineering, data science, and translational research. He has led cross-functional teams in the development of advanced imaging technologies, data platforms, and AI-driven tools for neuroscience. Dr. Pinskiy has published extensively in the fields of neuroimaging and computational biology and has overseen large-scale research programs spanning academia and industry.

Don Ewer

Managing partner, Alts Ventures

Our Advisors

Dr Duncan Moore

FORMER GLOBAL HEAD OF HEALTHCARE RESEARCH AT MORGAN STANLEY

Dr Michelle Tempest

FOUNDING MANAGING PARTNER AT CANDESIC, ANGEL INVESTOR IN BRAIN HEALTH, AUHTOR of the BIG BRAIN REVOLUTION, PSYCHIATRIST

Dr Richard Christie

FORMER Global Head, Development Science & Innovation; Head, External Development Group at ROCHE

A distinct culture focused on research & clinical excellence, and patient outcomes

Our culture is built on the belief that true innovation happens at the intersection of disciplines. We intentionally bring together individuals from diverse backgrounds each with deep expertise and a shared commitment to impact. We foster a passionate, research-driven environment grounded in scientific rigor, intellectual curiosity, and a relentless pursuit of better outcomes. Our work is guided by a strong ethical foundation and a patient-first mindset, where excellence in discovery goes hand-in-hand with meaningful clinical translation.